Bacteriophage-Fused Peptides for Serodiagnosis of Human Strongyloidiasis

PLoS Neglected Tropical Diseases

Volumn 8, Issue 5, 2014, Pages

  Feliciano, Nágilla Daliane ^a   Ribeiro, Vanessa da Silva ^a   Santos, Fabiana de Almeida Araújo ^a   Fujimura, Patricia Tiemi ^a   Gonzaga, Henrique Tomaz ^a   Goulart, Luiz Ricardo ^a,b   Costa Cruz, Julia Maria ^a  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOPHAGE FUSED PEPTIDE; BIOLOGICAL MARKER; COMPLEMENT COMPONENT C9; IMMUNOGLOBULIN G; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 7; UNCLASSIFIED DRUG; VIRUS FUSION PROTEIN; HELMINTH ANTIBODY; PARASITE ANTIGEN; PEPTIDE; PEPTIDE LIBRARY;

ARTICLE; BIOINFORMATICS; BIOPANNING; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMORAL IMMUNITY; IMMUNOREACTIVITY; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PREVALENCE; QUANTITATIVE ASSAY; RETROSPECTIVE STUDY; SAMPLING; SERODIAGNOSIS; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; ADOLESCENT; ADULT; AGED; ANIMAL; BACTERIOPHAGE; BLOOD; CHEMISTRY; DIAGNOSTIC USE; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; PARASITOLOGY; PEPTIDE LIBRARY; PROCEDURES; SENSITIVITY AND SPECIFICITY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; BACTERIOPHAGES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PARASITOLOGY; PEPTIDE LIBRARY; PEPTIDES; SENSITIVITY AND SPECIFICITY; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; YOUNG ADULT;

EID: 84901760327     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002792     Document Type: Article

References (54)

1. Siddiqui AA, Berk SL, (2001) Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 33: 1040-1047.
2. Buonfrate D, Anghebem A, Gobbi F, Muñoz J, Requena-mendez A, Gotuzzo E, Mena MA, Bisoffi Z, (2012) Imported strongyloidiasis: epidemiology, presentations, and treatment. Curr Infect Dis Rep 14: 256-262.
3. Schär F, Trostdorf U, Giardina F, Khieu V, Muth S, et al. (2013) Strongyloides stercoralis: Global distribution and risk factors. PLoS Negl Trop Dis 7(7): e2288 doi:10.1371/journal.pntd.0002288.
4. Montes M, Sawhney C, Barros N, (2010) Strongyloides stercoralis: there but not seen. Curr Opin Infect Dis 23: 500-504.
5. Grove DI, (1996) Human strongyloidiasis. Adv Parasitol 38: 251-309.
6. Khieu V, Srey S, Schär F, Muth S, Marti H, et al. (2013) Strongyloides stercoralis is a cause of abdominal pain, diarrhea and urticaria in rural Cambodia. BMC Res Notes 6: 200.
7. Ferreira MS, Nishioka SA, Borges AS, Costa-Cruz JM, Rossin IR, et al. (1999) Strongyloidiasis and infection due to human immunodeficiency virus: 25 cases at a Brazilian Teaching Hospital, including seven cases of hyperinfection syndrome. Clin Infect Dis 28: 154-155.
8. Oliveira LCM, Ribeiro CT, Mendes DM, Oliveira TC, Costa Cruz JM, (2002) Frequency of Strongyloides stercoralis infection in alcoholics. Mem Inst Oswaldo Cruz 97: 119-121.
9. Roxby AC, Gottlieb GS, Limaye AP, (2009) Strongyloidiasis in transplant patients. Clin Infect Dis 49: 1411-1423.
10. Marcos LA, Terashima A, Canales M, Gotuzzo E, (2011) Update on strongyloidiasis in the immunocompromised host. Curr Infect Dis Rep 13: 35-46.
11. Liu LX, Weller PF, (1993) Strongyloidiasis and other intestinal nematode infections. Infect Dis Clin North Am 37: 655-682.
12. Sato Y, Kobayashi J, Toma H, Shiroma Y, (1995) Efficacy of stool examination for detection of Strongyloides infection. Am J Trop Med Hyg 53: 248-250.
13. Koczka CP, Hindy P, Goodman A, Gress F, (2012) Strongyloidiasis: a diagnosis more common than we think. Eur J Gastroenterol Hepatol 24: 860-862.
14. Costa-Cruz JM, Bullamah CB, Gonçalves-Pires MRF, Campos DM, Vieira MA, (1997) Cryo-microtome sections of coproculture larvae of Strongyloides stercoralis and Strongyloides ratti as antigen sources for the immunodiagnosis of human strongyloidiasis. Rev Inst Med Trop São Paulo 39: 313-317.
15. Mota-Ferreira DML, Gonçalves-Pires MRF, Ferreira-Júnior A, Sopelete MC, Abdallah VOS, et al. (2009) Specific IgA and IgG antibodies in paired serum and Bread Milk samples in human strongyloidiasis. Act Trop 109: 103-107.
16. Rodrigues RM, Sopelete MC, Silva DAO, Cunha-Junior JP, Taketomi EA, et al. (2004) Strongyloides ratti antigenic components recognized by IgE anti bodies in immunoblotting as an additional tool for improving the immunodiagnosis in human strongyloidiasis. Mem Inst Oswaldo Cruz 99: 89-93.
17. Silva LP, Barcelos IS, Passos-Lima AB, Espindola FS, Campos DM, et al. (2003) Western Blotting using Strongyloides ratti antigen for the detection of IgG antibodies as confirmatory test in human strongyloidiasis. Mem Inst Oswaldo Cruz 98: 687-689.
18. Feliciano ND, Gonzaga TH, Gonçalves-Pires RF, Gonçalves ALR, Rodrigues RM, et al. (2010) Hydrophobic fractions from Strongyloides venezuelensis for use in the human immunodiagnosis of strongyloidiasis. Diagn Microbiol Infect Dis 67: 153-161.
19. Costa-Cruz JM, Bullamah CB, Gonçalves-Pires MRF, Campos DMB, (1998) Soroepidemiological study of human strongyloidiasis with blood samples collected on filter paper, in Abadia dos Dourados (Minas Gerais, Brazil). Rev Inst Med Trop São Paulo 40: 329-331.
20. Rossi CL, Takahashi EE, Teixeira AL, Barros-Mazon S, Trevisan RC, (1993) Avaliação de preparações antigênicas de Strongyloides stercoralis para o imunodiagnóstico da estrongiloidíase. Soc Bras Med Trop 26: 83-87.
21. Lindo JF, Conway DJ, Atkins NS, Bianco AE, Robinson RD, et al. (1994) Prospective evaluation of enzyme-linked immunosorbent assay and immunoblot methods for the diagnosis of endemic Strongyloides stercoralis infection. Am J Trop Med Hyg 51: 175-179.
22. Sithithaworn P, Srisawangwong T, Tesana S, Daenseekaew W, Sithithaworn J, (2003) Epidemiology of Strongyloides stercoralis in north-east Thailand: application of the agar plate culture technique compared with the enzyme-linked immunosorbent assay. Trans R Soc Trop Med Hyg 97: 398-402.
23. Requena-Méndez A, Chiodini P, Bisoffi Z, Buonfrate D, Gotuzzo, et al, (2013) The laboratory diagnosis and follow up of strongyloidiasis: a systematic review. J PLoS Negl Trop Dis 7(1): e2002 doi: 10.1371/journal.pntd.0002002.
24. Lang JS, Zhan JB, Xu LH, Yan ZK, (2006) Identification of peptide mimetics of xenoreactive α-Gal antigenic epitope by phage display. Biochem Biophys Res Commun 344: 214-220.
25. Ramanathan R, Burbelo PD, Groot S, Iadarola MJ, Neva FA, et al. (2008) A Luciferase immunoprecipitation systems assay enhances the sensitivity and specificity of diagnosis of Strongyloides stercoralis infection. J Infect Dis 198: 444-451.
26. Krolewiecki AJ, Ramanathan R, Fink V, McAuliffe I, Cajal SP, et al. (2010) Improved diagnosis of Strongyloides stercoralis using recombinant antigen-based serologies in a community-wide study in Northern Argentina. Clin Vaccine Immunol 17: 1624-1630.
27. Prudencio CR, Marra AO, Cardoso R, Goulart LR, (2010) Recombinant peptides as new immunogens for the control of the bovine tick, Rhipicephalus (Boophilus) microplus. Vet Parasitol 172: 122-131.
28. Hashemi H, Pouyanfard S, Bandehpour M, Noroozbabaei Z, Kazemi B, et al. (2012) Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza a virus challenge. PLoS One. 7(9): e45765 doi:10.1371/journal.pone.0045765.
29. Miller KR, Koide A, Leung B, Fitzsimmons J, Yoder B, et al. (2012) T cell receptor-like recognition of tumor in vivo by synthetic antibody fragment. PLoS ONE 7(8): e43746 doi:10.1371/journal.pone.0043746.
30. Sun N, Funke SA, Willbold D (2012) Mirror image phage display - Generating stable therapeutically and diagnostically active peptides with biotechnological means. J Biotechnol 161: 121125125.
31. Cortese R, Felici F, Galfre G, (1994) Epitope discovery using peptide libraries displayed on phage. Trends Biotechnol 12: 262-265.
32. Cortese R, Monaci P, Luzzago A, Santini C, Bartoli F, et al. (1996) Selection of biologically active peptides by phage display of random peptide libraries. Curr Opin Biotechnol 7: 616-619.
33. Smith GP, Petrenko VA, (1997) Phage Display. Chem Rev 97: 391-410.
34. Rodi DJ, Makowski L, (1999) Phage-display technology-finding a needle in a vast molecular haystack. Curr Opin Biotechnol 10: 87-92.
35. Ribeiro SV, Manhani MN, Cardoso R, Vieira CU, Goulart LR, et al. (2010) Selection of high affinity peptide ligands for detection of circulating antibodies in neurocysticercosis. Immunol Lett 129: 94-99.
36. Baermann (1917) Eine Einfache Methode zur Auffindung Von Ankylostomum (Nematoden) -Larven in Erdproden. Welteureden. Batavia: Genesk Lab Feestbundel. pp. 41-47.
37. Moraes RG, (1948) Contribuição para o estudo do Strongyloides stercoralis e da estrongiloidíase no Brasil. Rev Serv Esp Saúde Púb 64: 507-624.
38. Lutz A, (1919) O Schistosomum mansoni e a schistosomatose segundo observações feitas no Brasil. Mem Inst Oswaldo Cruz 11: 121-155.
39. Johnstone AP, Thorpe R (1987) Immunochemistry in practice. Blackwell Science.
40. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ, (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 29: 265-275.
41. Barbas CF III, Burton DR, Scott JK, Silverman GJ (2001) Phage display: a laboratory manual. New York, Cold Spring Harbor Laboratory Press, USA 738pp.
42. Greiner M, Sohr D, Göbel P, (1995) A modified ROC analysis for the selection of cut-off values and the definition of intermediate results of serodiagnostic tests. J Immunol Methods 185: 123-132.
43. Martinez EZ, Louzada-Neto F, Pereira BB, (2003) A curva ROC para testes diagnósticos. Cadernos de Saúde Coletiva 11: 7-31.
44. Hanley JA, McNeil BJ, (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148: 839-843.
45. Dreyer G, Fernandes-Silva E, Alves S, Rocha A, Albuquerque R, et al. (1996) Patterns of detection of Strongyloides stercoralis in stool specimens: implications for diagnosis and clinical trials. J Clin Microbiol 34: 2569-2571.
46. Greiner K, Bettencourt J, Semolic C, (2008) Strongyloidiasis: a review and update by case example. Clin Lab Sci 21: 82-88.
47. Gonzaga HT, Ribeiro VS, Feliciano ND, Manhani MN, Silva DAO, et al. (2011) IgG avidity differential serodiagnosis of human strongyloidiasis active infection. Immunol Lett 139: 87-92.
48. Hutchinson OC, Webb H, Picozzi K, Welburn S, Carrington M, (2004) Candidate protein selection for diagnostic markers of African trypanosomiasis. Trends Parasitol 11: 519-523.
49. Van Nieuwenhove L, Büscher P, Balharbi F, Humbert M, Dieltjens T, et al. (2012) Identification of mimotopes with diagnostic potential for Trypanosoma brucei gambiense variant surface glycoproteins using human antibody fractions. PLoS Negl Trop Dis 6(6): e1682 doi:10.1371/journal.pntd.0001682.
50. Ramachandran S, Thompson RW, Gam AA, Neva FA, (1998) Recombinant cDNA clones for immunodiagnosis of strongyloidiasis. J Infect Dis 177: 196-203.
51. Folgori A, Tafi R, Meola A, Felici F, Galfré G, et al. (1994) A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera. Embo J13: 2236-2243.
52. Palacios-Rodríguez Y, Gazarian T, Huerta L, Gazarian K, (2011) Constrained peptide models from phage display libraries highlighting the cognate epitope-specific potential of the anti-HIV-1 mAb 2F5. Immunol Lett 136: 80-89.
53. Manhani MN, Ribeiro VS, Cardoso R, Ueira-Vieira C, Goulart LR, et al. (2011) Specific phage-displayed peptides discriminate different forms of neurocysticercosis by antibody detection in the serum samples. Parasite Immunol 33: 322-329.
54. Gazarian K, Rowlay M, Gazarian T, Buchelli JEV, Gonzáles MH, (2012) Mimotope peptides selected from phage display combinatorial library by serum antibodies of pigs experimentally infected with Taenia solium as leads to developing diagnostic antigens for human neurocysticercosis. Peptides 38: 381-388.